Nexentis Technologies Inc. (NXTS) stock
NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.64−0.00 (-0.73%)
Close on Oct 19, 2026Market cap $522.65KP/E –Yield –
Nexentis Technologies gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Nexentis Technologies's gross profit for the twelve months ending Sep 30, 2025 was $136.00K, up 70.8% year over year. For fiscal 2024 it was $45.00K, down 78.4% from the year before. The highest annual figure on record is $315.50K in fiscal 2018.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $45.00K | -78.4% |
| FY2023 | Dec 31, 2023 | $208.00K | -11.7% |
| FY2022 | Dec 31, 2022 | $235.69K | -22.0% |
| FY2021 | Dec 31, 2021 | $302.20K | +60.0% |
| FY2020 | Dec 31, 2020 | $188.87K | +503.9% |
| FY2019 | Dec 31, 2019 | $31.28K | -90.1% |
| FY2018 | Dec 31, 2018 | $315.50K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | $0 | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.00K | -118.2% |
| Q1 FY2025 | Mar 31, 2025 | $52.00K | +225.0% |
| Q4 FY2024 | Dec 31, 2024 | $86.00K | -28.7% |
| Q3 FY2024 | Sep 30, 2024 | -$68.00K | – |
| Q2 FY2024 | Jun 30, 2024 | $11.00K | +14.6% |
| Q1 FY2024 | Mar 31, 2024 | $16.00K | -79.6% |
| Q4 FY2023 | Dec 31, 2023 | $120.61K | -16.8% |
| Q3 FY2023 | Sep 30, 2023 | -$476 | -101.8% |
| Q2 FY2023 | Jun 30, 2023 | $9.60K | -46.9% |
| Q1 FY2023 | Mar 31, 2023 | $78.26K | +71.0% |
| Q4 FY2022 | Dec 31, 2022 | $145.00K | +19.5% |
| Q3 FY2022 | Sep 30, 2022 | $26.83K | +51.4% |
| Q2 FY2022 | Jun 30, 2022 | $18.08K | -58.0% |
| Q1 FY2022 | Mar 31, 2022 | $45.78K | -61.9% |
| Q4 FY2021 | Dec 31, 2021 | $121.29K | -19.7% |
| Q3 FY2021 | Sep 30, 2021 | $17.72K | – |
| Q2 FY2021 | Jun 30, 2021 | $43.05K | – |
| Q1 FY2021 | Mar 31, 2021 | $120.14K | +180.8% |
| Q4 FY2020 | Dec 31, 2020 | $150.99K | +26067.9% |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.91K | – |
| Q1 FY2020 | Mar 31, 2020 | $42.79K | -55.3% |
| Q4 FY2019 | Dec 31, 2019 | $577 | – |
| Q3 FY2019 | Sep 30, 2019 | $0 | – |
| Q2 FY2019 | Jun 30, 2019 | -$64.99K | – |
| Q1 FY2019 | Mar 31, 2019 | $95.69K | – |
See a number that looks wrong?